Effects of Camouflage on the Life Quality of Patients With Vitiligo

Launched by XIJING HOSPITAL · May 17, 2018

Keywords

ClinConnect Summary

Vitiligo is a common depigmented skin disease characterized by destruction of functional melanocyte. The global incidence is about 0.5-2.0% and prevalence be about 0.8-1.5% in China. Studies showed that almost half of vitiligo patients had developed depigmentation before 20 years old. Lesions involving exposed skin such as face, hand or mucous always make patients feeling embarrassment, so the impaired quality of life (QoL) have greater impact on patients with vitiligo than the disease itself. Besides, Vitiligo is also a psychosomatic disease as its cause stress or depression which can indu...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects who signed Informed Consent Form；
• • Male or female subjects 18-64 years of age；
• • Clinically confirmed diagnosis of vitiligo as per the diagnostic criteria for vitiligo specified in Clinical Dermatology.
• Exclusion Criteria:
• • Incompliance with the diagnosis of vitiligo.
• • Patients who had used other camouflage before;
• • Cannot read or understand questionnaire.
• • Patients who had taken antidepressants in the last three months had psychiatric and psycho-related illnesses.；
• • Inability to guarantee taking medications and completing visits as scheduled during the study;
• • Allergic history of any relevant ingredient in the camouflage;
• • The combination of eczema, contact dermatitis, urticaria and other allergic diseases or other serious diseases which are not suitable for the treatment of skin diseases；
• • Serious life-threatening condition such as cancer, autoimmune diseases；
• • Women of child-bearing potential who are pregnant, plan to become pregnant during study or are lactating；
• • Participating in other clinical studies or within 3 months;
• • Any other condition that the investigator deems unsuitable for entering the study.